Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

Deals > All

Total search results: 9582 | Ordered by Date (descending)
1 2 3 ... 94 95 96  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Cantor Fitzgerald: investor conference, 201809 supply service Evotec presents at Cantor Fitzegerald Global Healthcare Conference in NY 2018-10-01
Evotec–Berenberg: investor conference, 201809 supply service Evotec attends 7th German Corporate Conference in Munich 2018-09-26
Evotec–Baader Bank: investor conference, 201809 supply service Evotec attends Baader Investment Conference 2018 in Munich 2018-09-24
Bruker Corp–Morgan Stanley: investor conference, 201809 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY 2018-09-13
Evotec–Morgan Stanley: investor conference, 201809 supply service Evotec presents at Morgan Stanley Global Healthcare Conference NY 2018-09-13
Evotec–JPMorgan Chase: investor conference, 201809 supply service Evotec at JP Morgan Cazenove Pan-European Small/Mid Cap Conference London 2018-09-12
Thermo Fisher–Morgan Stanley: investor conference, 201809 supply service Thermo Fisher presents at Morgan Stanley Global Healthcare Conference 2018-09-12
Menarini–Lunaphore: staining technology, 201809– collab Menarini Diagnostics to market LabSat Frozen tissue staining solution 2018-09-09
Evotec–Goldman Sachs: investor conference, 201809 supply service Evotec at 8th Annual Biotech Symposium in London 2018-09-07
Uniqure–Goldman Sachs: investor conference, 201809 supply service Uniqure presents at 8th Annual Biotech Symposium in London 2018-09-07
Uniqure–Janney Montgomery Scott: investor conference, 201809 supply service Uniqure presents at Janney Healthcare Conference in New York 2018-09-07
Affimed–Wells Fargo: investor conference, 201809 supply service Affimed presents at Wells Fargo Healthcare Conference in Boston 2018-09-06
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform 2018-09-06
Novartis–Aurobindo: investment, 201809 acquisition $900m cash + $100m milestones of Sandoz US dermatology + oral generics businesses by Aurobindo USA 2018-09-06
Adaptimmune–Matrix Capital Manamagent: investment, 201809 registered direct offering totalling $100m incl existing investor Matrix Capital 2018-09-05
Adaptimmune–New Enterprise Associates: investment, 201809 registered direct offering totalling $100m incl existing investor NEA 16 LP + NEA 14 LP 2018-09-05
Adaptimmune–SEVERAL: investment, 201809 registered direct offering $100m of 10m ADSs at $10/ADS to Matrix Capital + NEA + Syncona 2018-09-05
Adaptimmune–Wellcome Trust: investment, 201809 registered direct offering totalling $100m incl new investor Syncona Portfolio Ltd 2018-09-05
Pieris–Rodman & Renshaw: investor conference, 201809 supply service Pieris presents at Rodman & Renshaw Global Investment Conference 2018 in NY 2018-09-05
Uniqure–Citigroup: investor conference, 201809 supply service Uniqure participates in Citi’s 13th Annual Biotech Conference in Boston 2018-09-05
Uniqure–Wells Fargo: investor conference, 201809 supply service Uniqure presents at Wells Fargo Healthcare Conference in Boston 2018-09-05
Azeria Therapeutics–Sixth Element Capital: investment, 201709 Series A investment £4m from CRT Pioneer Fund 2018-09-04
Clinical Research Laboratories (US)–Eurofins: investment, 201809 acquisition of CRL by Eurofins 2018-09-04
Miracor–SEVERAL: investment, 201809 financing round Series D totalling €30m final closing led by Ming Capital (CN) 2018-09-04
Optibrium–Enamine: chemical compound libraries, 201809– collab free access to EnamineStore database for StarDrop users 2018-09-04
Evox Therapeutics–Alphabet: investment, 201809 financing round Series B totalling £35.5m incl new investor GV 2018-09-03
Evox Therapeutics–Borealis Ventures: investment, 201809 financing round Series B totalling £35.5m incl new investor Borealis Ventures 2018-09-03
Evox Therapeutics–Cowen: investment, 201809 financing round Series B totalling £35.5m incl new investor Cowen Healthcare Investments 2018-09-03
Evox Therapeutics–Panacea Healthcare Venture: investment, 201809 financing round Series B totalling £35.5m incl new investor PHV 2018-09-03
Evox Therapeutics–Redmile Group: investment, 201809 financing round Series B totalling £35.5m incl new + lead investor Redmile Group 2018-09-03
Evox Therapeutics–SEVERAL: investment, 201809 financing round Series B totalling £35.5m incl small number of private investors 2018-09-03
Evox Therapeutics–SEVERAL: investment, 201809 financing round Series B £35.5m led by Redmile Group 2018-09-03
Evox Therapeutics–Univ Oxford: investment, 201809 financing round Series B totalling £35.5m incl existing investors OSI + Oxford Univ 2018-09-03
CHDI–Evotec: drug discovery services, 201808–2023 collab service extension CDHI funding up to 75 full-time scientists for Huntington’s disease drugs 2018-08-30
Genomics Medicine Ireland–Univ Cambridge: genomics, 201808– collab using 15000 DNA-extracted MS samples from biobank of Prof Sawcer 2018-08-30
Genomics plc–FTI Consulting: public relations, 201808 service existent by FTI Consulting 2018-08-30
Genomics plc–Invesco: investment, 201808 financing round Series B totalling £25m incl existing + co-investor Invesco Perpetual 2018-08-30
Genomics plc–IP Group: investment, 201808 financing round Series B totalling £25m incl existing + co-investor IP Group 2018-08-30
Genomics plc–Lansdowne Partners: investment, 201808 financing round Series B totalling £25m incl existing + co-investor Lansdowne Partners 2018-08-30
Genomics plc–SEVERAL: investment, 201808 financing round Series B £25m led by Vertex + incl IP Group + Woodford et al 2018-08-30
Genomics plc–Tanarra: investment, 201808 financing round Series B totalling £25m incl co-investor Tamorer Pty Ltd 2018-08-30
Genomics plc–Univ Oxford: investment, 201808 financing round Series B totalling £25m incl co-investor Oxford Sciences Innovation 2018-08-30
Genomics plc–Vertex: investment, 201808 financing round Series B totalling £25m incl lead investor Vertex in connection with collab 2018-08-30
Genomics plc–Woodford Investment: investment, 201808 financing round Series B totalling £25m incl existing + co-investor Woodford Investment 2018-08-30
Lunaphore–SEVERAL: investment, 201808 financing round Series B CHF5.3m from existing + new investors 2018-08-30
Vertex–Genomics plc: bioinformatics, 201808– collab expansion using human genetics + data science for target discovery + personalised medicine 2018-08-30
Kandy Therapeutics–Advent Venture Partners: investment, 201808 financing round Series C totalling £25m incl existing investor Advent Life Sciences 2018-08-29
Kandy Therapeutics–Forbion: investment, 201808 financing round Series C totalling £25m incl existing investor Forbion Capital Partners 2018-08-29
Kandy Therapeutics–Fountain Healthcare Partners: investment, 201808 financing round Series C totalling £25m incl existing investor Fountain HCP 2018-08-29
Kandy Therapeutics–Longitude Capital: investment, 201808 financing round Series C totalling £25m incl new investor Longitude Capital 2018-08-29
Kandy Therapeutics–OrbiMed Advisors: investment, 201808 financing round Series C totalling £25m incl existing investor OrbiMed 2018-08-29
Kandy Therapeutics–SEVERAL: investment, 201808 financing round Series C £25m from Longitude Capital + Advent LS + Fountain HCP + Forbion + OrbiMed 2018-08-29
Nebula Genomics–Heartbeat Labs: investment, 201808 seed financing round totalling $4.3m incl Heartbeat Labs 2018-08-29
Nebula Genomics–Hikma: investment, 201808 seed financing round totalling $4.3m incl Hikma Ventures 2018-08-29
Nebula Genomics–SEVERAL: investment, 201808 seed financing round $4.3m from ten leading tech + biotech VCs 2018-08-29
Congenica–Instinctif Partners: public relations, 201808 service existent by Instinctif 2018-08-28
PhagoMed–Austria (govt): grant, 201808–2021 research project grant €3.5m from FFG 2018-08-28
PhagoMed–Austria (govt): investment, 201808 seed financing round totalling €1.55m incl €800k aws-Seedfinancing 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round totalling €1.55m incl €750k from private investors 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round €1.55m from private investors + aws 2018-08-28
Evotec–Centogene: drug discovery, 201808– collab ww strategic €na discovery + developm of treatments for rare genetic diseases 2018-08-27
Roche–Affimed: antibody cancer drug, 201808– collab $96m ufpront + $5b milestones + royalties using ROCK platform to develop ABs with Genentech 2018-08-27
Thermo Fisher–BioStrata: public relations, 201808 service existent by BioStrata 2018-08-27
Univ Wisconsin–Thermo Fisher: FAIMS technology, 201808 supply use of FAIMS device for shotgun proteomics by Joshua Coon 2018-08-27
Hain Lifescience–Bruker Corp: investment, 201808– acquisition €na of 80% majority interest with option to acquire rest in 2012 ANNOUNCED 2018-08-24
c-LEcta–Capricorn Venture Partners: investment, 201808 financing round incl new + lead investor Capricorn investing via CSCF NV + Quest for Growth 2018-08-23
c-LEcta–SEVERAL: investment, 201808 financing round €na with new investors Capricorn Venture Partners + bm|t 2018-08-23
c-LEcta–Thuringia (govt): investment, 201808 financing round incl new + co-investor bm|t via MFT Mittelstands-Fonds Thüringen 2018-08-23
Novaremed–SEVERAL: investment, 201804 financing round CHF4.44m to support phase 2b study of NRD.E1 in DNP 2018-08-23
Novaremed–SEVERAL: investment, 201808 financing round CHF6m to support phase 2b study of NRD.E1 in DNP 2018-08-23
Merck (DE)–GlucoMe: digital health, 201808– collab digital diabetes management project in Vietnam 2018-08-22
Novo Group–Evotec: drug discovery services, 201808– collab €na strategic alliance r+d small molecule drugs for diabetes + obesity Novo Nordisk 2018-08-22
SolasCure–BRAIN: investment, 201808 financing round Series A with participation of BRAIN at spin-off of SolasCure from BRAIN 2018-08-22
SolasCure–BRAIN: wound care product, 201808– license IP for Aurase enzyme + supply of enzymatic active ingredient by BRAIN to SolasCure 2018-08-22
SolasCure–SEVERAL: investment, 201808 financing round Series A with participation of BRAIN 2018-08-22
Bavarian Nordic–PCI Biotech: PCI technology, 201808– collab research preclinical evaluation of integration of technologies from both companies 2018-08-20
Genkyotex–Yorkville Group: credit, 201808– up to €7.5m convertible notes with attached warrants in 2 tranches with YA II PN Ltd 2018-08-20
Ziylo–Novo Group: investment, 201808 acquisition 100% for up to $800m in upfront + milestone payments by Novo Nordisk 2018-08-17
Abzena–Welsh Carson Anderson & Stowe: investment, 201808– recommended cash offer 16p/share valueing Abzena at £34.4m by WCAS XII-Astra LP 2018-08-16
NuGen–Tecan: investment, 201808 acquisition $54.5m in cash by Tecan 2018-08-16
Oncologie–Mologen: lefitolimod, 201808– term sheet for acquisition of ww rights to lefitolimod by Oncologie 2018-08-15
Argen-X–Wedbush: investor conference, 201808 supply service Argenx presents at Wedbush PacGrow Healthcare Conference in NYC 2018-08-14
Bayer–Haplogen: antiviral agents, 201808– collab €na developm candidates for pulmonary diseases incl COPD 2018-08-14
Blueberry Therapeutics–Bryan Garnier: financial services, 201808 supply service financial advisor with regard to £10m Series B financing round 2018-08-14
Blueberry Therapeutics–China Medial System: investment, 201808 financing round Series B totalling £10m incl China Medical Venture Investment (HK) Ltd 2018-08-14
Blueberry Therapeutics–Onyx Health: public relations, 201808 service existent by Onyx Health PR 2018-08-14
Blueberry Therapeutics–PERSON: investment, 201808 financing round Series B totalling £10m incl investor A&B (HK) Ltd 2018-08-14
Blueberry Therapeutics–SEVERAL: investment, 201808 financing round Series B £10m from China Medical Venture Investment + A&B (HK) 2018-08-14
Blueberry Therapeutics–Slater Heelis: legal services, 201808 supply service legal advisor with regard to £10m Series B financing round 2018-08-14
Orchard Therapeutics–SEVERAL: investment, 201808 financing round Series C $150m led by Deerfield Management 2018-08-13
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Optimum Strategic Communications: public relations, 201808 service existent by Optimum 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
1 2 3 ... 94 95 96  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px

» top